COMMUNIQUÉS West-GlobeNewswire

US Digestive Health Celebrates Grand Opening of Lansdale-Colmar Office
15/02/2024
EXTON, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) -- US Digestive Health (USDH), one of the nation's largest gastroenterology (GI) practices, celebrated the opening of its new Lansdale-Colmar office on Wednesday, February 7, [...]
Health Coalition Exposes Significantly Higher Costs & Irregularities in Kingston Hospital Cataract Surgery Privatization: New Report
15/02/2024
The privatization of cataract surgeries in Kingston, Ontario, costs 56% more than if the same procedures had been done in a public hospital, reports the Kingston Health Coalition (KHC). KINGSTON, Ontario, Feb. 15, 2024 [...]
BioNTX Champions Talent Retention in the Texas Life Sciences Industry
15/02/2024
DALLAS, Feb. 15, 2024 (GLOBE NEWSWIRE) -- BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas, continues its commitment to nurturing the thriving, regional, life science [...]
Shamir Medical Center Reveals New Long-Term Results from Long COVID Study to Highlight Positive Impact on Symptoms Resulting from Hyperbaric Oxygen Therapy
15/02/2024
The study looked at patients with long COVID and their results from hyperbaric oxygen therapy after one year ORLANDO, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Today, Aviv Clinics reveals results from the Sagol Center for [...]
OnKure Announces the Appointment of Samuel Agresta, M.D., as Chief Medical Officer
15/02/2024
BOULDER, Colo., Feb. 15, 2024 (GLOBE NEWSWIRE) -- OnKure, Inc. today announced the appointment of Samuel Agresta, M.D., M.P.H. as Chief Medical Officer. Dr. Agresta brings more than 15 years of leadership experience in [...]
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
15/02/2024
A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing. Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood. [...]
Merit Medical Receives FDA 510(k) Clearance for SCOUT® MD™ Surgical Guidance System
15/02/2024
New guidance system marks significant advancement in breast cancer care, targeting tumor location in multiple dimensions for precise excision and successful surgeries SOUTH JORDAN, Utah, Feb. 15, 2024 (GLOBE NEWSWIRE [...]
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference Call
15/02/2024
WOBURN, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 fourth quarter and year end business and financial highlights before the opening of the [...]
Healthcare Triangle Announces Cost Reduction Initiatives to Achieve Profitability
15/02/2024
Strategic initiatives are expected to generate an estimated annualized savings of $3 million – $4 million in FY2024 PLEASANTON, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc (Nasdaq: HCTI) (“HCTI” [...]
Sirona Biochem Engages Global Beauty Consulting
15/02/2024
VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) has announced its partnership with Global Beauty Consulting – [...]
Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy
15/02/2024
– Findings demonstrate significant reduction in pain and opioid consumption through 96 hours versus active comparator – – Significantly greater proportion of opioid-free patients receiving EXPAREL – TAMPA, Fla., Feb. 15 [...]
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
15/02/2024
Carlsbad, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal [...]
G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
15/02/2024
RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate [...]
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
15/02/2024
CAMBRIDGE, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that it will report its fourth- [...]
Sienna Announces February Dividend
15/02/2024
MARKHAM, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
Cerevance Announces Publication of CVN766 in Bioorganic & Medicinal Chemistry Letters
15/02/2024
Highly selective Orexin 1 antagonist may have treatment potential in multiple therapeutic conditions BOSTON, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for [...]
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
15/02/2024
DELRAY BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS), received on February 13, 2024, a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that [...]
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
15/02/2024
FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, [...]
CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit
15/02/2024
ZUG, Switzerland and BOSTON, Feb. 15, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]

Pages